DIMENSIONAL FUND ADVISORS LP

Position in KROS — Keros Therapeutics, Inc.

CIK 354204 AUSTIN, TX

Position in KROS

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$4,927,786

+$1,379,973 QoQ

Shares Held

460,541

+43.3% QoQ

Ownership

2.32%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#14

of 132 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 90% Shared 8% None 2%

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. KROS ranks #106 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,168,956	$580,655,511
2	JAZZ	Jazz Pharmaceuticals plc	1,713,592	$412,924,262
3	REGN	Regeneron Pharmaceuticals, Inc.	559,687	$348,987,230
4	INCY	Incyte Corp	2,280,803	$258,551,825
5	EXEL	Exelixis, Inc.	4,426,620	$240,852,392
6	BMRN	Biomarin Pharmaceutical Inc	4,075,714	$233,212,353
7	ROIV	Roivant Sciences Ltd.	5,230,417	$185,104,455
8	KRYS	Krystal Biotech, Inc.	476,038	$176,929,041

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,927,786	460,541	+43.3%	Shares	Sole	2026-08-11
2026-03-31	$3,547,813	321,360	+453.9%	Shares	Sole	2026-05-07
2025-12-31	$1,181,143	58,013	+61.3%	Shares	Sole	2026-02-12
2025-09-30	$568,854	35,958	-1.9%	Shares	Sole	2025-11-12
2025-06-30	$489,090	36,636	0.0%	Shares	Sole	2025-08-12
2025-03-31	$373,320	36,636	-76.4%	Shares	Sole	2025-05-13
2024-12-31	$2,456,229	155,163	+1.8%	Shares	Sole	2025-02-13
2024-09-30	$8,851,956	152,436	-5.7%	Shares	Sole	2024-11-07
2024-06-30	$7,390,373	161,715	-2.2%	Shares	Sole	2024-08-09
2024-03-31	$10,949,876	165,406	-3.2%	Shares	Sole	2024-05-10
2023-12-31	$6,793,073	170,852	-0.2%	Shares	Sole	2024-02-07
2023-09-30	$5,460,307	171,277	+191.5%	Shares	Sole	2023-11-09
2023-06-30	$2,361,217	58,766	—	Shares	Sole	2023-08-09
No filing history on record for this holder in this stock.